Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTL) for the treatment of patients with EBV-positive relapsed nasopharingeal carcinoma

被引：0
|
作者：
Comoli, P
Pedrazzoli, P
Nocera, A
Labirio, M
Del Galdo, F
Basso, S
Schiavo, R
Tagliamacco, A
Carminati, O
De Palma, R
Siena, S
Locatelli, F
Maccario, R
机构：
来源：
BONE MARROW TRANSPLANTATION | 2002年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P709
引用
收藏
页码：S191 / S191
页数：1
相关论文
共 50 条
  • [1] Autologous Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed nasopharingeal carcinoma
    Comoli, P
    Basso, S
    Schiavo, R
    Moretta, A
    Labirio, M
    Carminati, O
    Del Galdo, F
    De Palma, R
    Siena, S
    Locatelli, F
    Maccario, R
    Pedrazzoli, P
    BONE MARROW TRANSPLANTATION, 2003, 31 : S207 - S207
  • [2] Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positiye relapsed Hodgkin's disease
    Roskrow, MA
    Suzuki, N
    Gan, YJ
    Sixbey, JW
    Ng, CYC
    Kimbrough, S
    Hudson, M
    Brenner, MK
    Heslop, HE
    Rooney, CM
    BLOOD, 1998, 91 (08) : 2925 - 2934
  • [3] Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease
    Lucas, KG
    Salzman, D
    Garcia, A
    Sun, O
    CANCER, 2004, 100 (09) : 1892 - 1901
  • [4] A PHASE II STUDY OF CARBOPLATIN AND DOCETAXEL FOLLOWED BY EPSTEIN-BARR VIRUS SPECIFIC CYTOTOXIC T LYMPHOCYTES FOR REFRACTORY/RELAPSED EBV-POSITIVE NASOPHARYNGEAL CARCINOMA
    Louis, C. U.
    Ramos, C.
    Kalra, M.
    Glisson, B.
    Liu, H.
    Herzog, C.
    Gee, A.
    Heslop, H. E.
    Brenner, M. K.
    Rooney, C.
    Gottschalk, S.
    CYTOTHERAPY, 2013, 15 (04) : S8 - S9
  • [5] Epstein-Barr Virus-specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas
    Jones, Kimberley
    Vari, Frank
    Khanna, Rajiv
    Han, Erica
    Singh, Sanjleena
    Ritchie, David
    Gandhi, Maher K.
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 944 - 945
  • [6] Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma
    Hoshikawa, Y
    Satoh, Y
    Murakami, M
    Maeta, M
    Kaibara, N
    Ito, H
    Kurata, T
    Sairenji, T
    JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (03) : 351 - 359
  • [7] Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma
    Sun, Q
    Burton, R
    Reddy, V
    Lucas, KG
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (03) : 799 - 808
  • [8] Epstein-Barr virus (EBV)-specific cytotoxic T cells to deliver transgenic interleukin 12 to EBV-positive Hodgkins's diseaase.
    Wagner, HJ
    Vigouroux, S
    Bollard, CM
    Huls, MH
    Anderson, R
    Prentice, GH
    Brenner, MK
    Heslop, HE
    Rooney, CM
    BLOOD, 2002, 100 (11) : 578A - 578A
  • [9] Multiplex Epstein-Barr virus (EBV) serology in EBV-positive and -negative gastric cancer
    Camargo, M. Constanza
    Michel, Angelika
    Kim, Kyoung-Mee
    Matsuo, Keitaro
    Liao, Linda M.
    Torres, Javier
    Zabaleta, Jovanny
    Gulley, Margaret L.
    Yatabe, Yasushi
    Alvarado-Cabrero, Isabel
    Lissowska, Jolanta
    Kim, Sung
    Pawlita, Michael
    Rabkin, Charles S.
    CANCER RESEARCH, 2014, 74 (19)
  • [10] Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection
    Savoldo, B
    Huls, MH
    Liu, ZS
    Okamura, T
    Volk, HD
    Reinke, P
    Sabat, R
    Babel, N
    Jones, JF
    Webster-Cyriaque, J
    Gee, AP
    Brenner, MK
    Heslop, HE
    Rooney, CM
    BLOOD, 2002, 100 (12) : 4059 - 4066
12345